A batch of Abhayrab rabies vaccine was seized from an unlicensed premises in Delhi and found to be misbranded and substandard. The DCGI has alerted all states to maintain strict surveillance.

  • A batch of Abhayrab rabies vaccine (Batch No. KE25012) was seized from an unlicensed site in Mukherjee Nagar, Delhi.
  • The Central Drugs Laboratory, Kasauli, declared the product 'misbranded' and 'not of standard quality.'
  • Four individuals have been arrested by the Delhi Police Crime Branch.
  • DCGI has issued a nationwide alert to state drug controllers to monitor the distribution of this batch.

In a major crackdown on illegal pharmaceutical networks, regulatory and law enforcement agencies have intensified their operations following the seizure of a misbranded batch of Abhayrab rabies vaccine. The seizure took place at an unlicensed premises in Mukherjee Nagar, Delhi, triggering a high-level alert from the Drugs Controller General of India (DCGI).

The investigation began when the Delhi Police Crime Branch, alongside officials from the Delhi Drugs Control Department, conducted a raid. The seized product, bearing batch number KE25012, was subsequently tested by the Central Drugs Laboratory in Kasauli. The laboratory's findings were alarming: the vaccine was not only misbranded but also failed to meet standard quality requirements and was not manufactured by the legitimate entity, Indian Immunologicals Ltd.

Read Also:FDA Takes Action Against Five Mumbai Cricket Association Outlets Over Food Safety Violations

Why This Matters

BozokMedia analysis shows that the infiltration of substandard or spurious vaccines into the supply chain represents a critical threat to public health. In the case of rabies—a disease with a near-100% fatality rate once symptoms appear—the integrity of the vaccine is the only line of defense between life and death.

The emergence of misbranded life-saving drugs highlights the urgent need for digitized, transparent supply chains to prevent unauthorized players from endangering lives.

Following the laboratory results, the DCGI issued a formal communication to all state drug controllers across India. States have been directed to maintain strict vigilance over the movement and availability of the affected batch and to initiate appropriate legal proceedings under the Drugs and Cosmetics Act, 1940.

Addressing the crisis, the manufacturer of Abhayrab clarified that all vaccines dispensed through authorized hospitals, clinics, and licensed pharmacies undergo rigorous quality-control and batch-release procedures. They further emphasized that no part of the compromised batch was exported to international markets, limiting the immediate global risk.

The Delhi Police have already arrested four individuals in connection with the unauthorized manufacturing and distribution. Authorities are continuing their investigation to dismantle the larger network behind this illegal operation.

Did You Know?: Rabies is one of the deadliest viruses on Earth, making the quality of post-exposure prophylaxis (PEP) absolutely vital for survival.

Frequently Asked Questions

1. Is the vaccine available in government hospitals safe?
Yes, vaccines supplied through authorized channels and government healthcare facilities follow regulated quality-control procedures.

2. What action has been taken against the perpetrators?
Four persons have been arrested by the Delhi Police, and legal action is ongoing under the Drugs and Cosmetics Act.